Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic test

Active
75D30126Q79099Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention is seeking quotes for the procurement of lateral flow (LFA) strips to support a rapid HIV nucleic acid diagnostic test under solicitation number 75D30126Q79099. This is a combined synopsis and solicitation issued as a Request for Quote under FAR Subpart 12, governing commercial item acquisitions, and will result in a firm-fixed-price contract. The period of performance is set from August 1, 2026, through December 31, 2026, with performance taking place at the CDC’s facility located at 1600 Clifton Road, Building 17, Atlanta, Georgia. All submissions must be made in writing by 3:00 p.m. Eastern Standard Time on Friday, July 24, 2026, and no telephonic responses will be accepted. Offerors must be registered in the System for Award Management at the time of submission and are responsible for familiarizing themselves with applicable Federal Acquisition Regulation clauses, including 52.212-1 and 52.212-4. Questions must be submitted no later than close of business on Monday, July 23, 2026, to Eugene L. Gutierrez Jr. at zvm0@cdc.gov. The acquisition falls under NAICS code 541714 with no set-aside designated, and the quote format is flexible at the offeror’s discretion.

General Info

CDC seeks firm-fixed-price quotes for HIV LFA strips from August to December 2026, with submissions due July 24, 2026.

Agency

Department Of Health And Human Services → CDC Office Of Acquisition ServicesView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Atlanta, GA, 30329, USA

Set-Aside

NONE

Documents

(1)

A19+-+75D30126Q79099+-+Final.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → CDC Office Of Acquisition Services
Contacts2 people available
OfficeATLANTA, GA, 30333, USA
Organization / Agency
Department Of Health And Human Services → CDC Office Of Acquisition Services
View Agency Profile
Office AddressATLANTA, GA, 30333, USA
Contacts
Eugene L. Gutierrez Jr
contact@example.gov
+1 (555) 000-0000
Liubov Kriel
contact@example.gov
+1 (555) 000-0000

Full Description

Show more

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Requirements (FAR) Subpart 12.202, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested.


The solicitation number for this requirement is 75D30126Q79099 and is hereby issued as a Request for Quote (RFQ) using FAR Subpart 12 - Acquisition of Commercial Products and Commercial Services.


The Centers for Disease Control and Prevention intends to award a firm-fixed-price contract, see the attached RFQ for more details and instructions to offerors.  See the CLINS and FAR Clauses and Provisions associated with this combined synopsis / solicitation in the attached RFQ.


Period of Performance: 08/01/2026 – 12/31/2026

Questions due by COB Monday July 23, 2026

Place of Performance:  Center for Disease Contron and Prevention
                                      1600 Clifton Road, Building 17
                                       Atlanta, GA 30329-4018


The quote format is at the discretion of the offeror.


It is the offeror's responsibility to be familiar with the applicable clauses and provisions. Clauses and provisions may be accessed via the Internet at website FAR | Acquisition.GOV.


This acquisition is under North American Industry Classification System (NAICS) code 541714.  A Firm-Fixed Price purchase order will be issued in writing to the successful offeror. To be eligible to receive an award resulting from this solicitation, contractor must be registered in the System for Award Management (SAM) at the time of quote submission.


FAR Provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, applies to this acquisition.


FAR clause 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services, applies to this acquisition.


No telephonic quotes will be processed. All responses must be received no later than 3:00 P.M., Eastern Standard Time on Friday, 24 July 2026. Please send any questions and quotes to Eugene Gutierrez, Contract Specialist at zvm0@cdc.gov.


Attachments:


1. RFQ – 75D30126Q79099
 

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Hypoxia Chamber ServicesNASA Johnson Space Center is soliciting offers for Hypoxia Chamber Services under solicitation number 80JSC026Q0008 to support research into the physiological, cognitive, and clinical effects of mild hypobaric hypoxia for the Artemis Program. The requirement includes comprehensive infrastructure, trained personnel, operational support, supplies, and materials necessary to conduct controlled hypoxia experiments. This is a combined synopsis and solicitation issued under FAR Subpart 12.6 for commercial items with no written solicitation to follow. Offerors must comply with FAR provisions including 52.212-1, 52.212-2, 52.212-3, and 52.212-4, and must submit completed representations and certifications through SAM.gov. Evaluation priorities are Technical Acceptability and Past Performance, which are significantly more important than Price, though Price becomes increasingly influential when technical proposals are closely matched. The NAICS code is 541714 with a size standard of 1000 employees, and offerors must declare their size status. All submissions must be sent via email to Joshua Hlavenka and Katelyn Jaime by 1:00 PM CST on August 24, 2026, and technical or contractual inquiries must be submitted electronically by July 29, 2026. Additional requirements are detailed in Attachment D, and full terms are governed by FAR and NFS clauses. The place of performance is Houston, Texas, and no set-aside is applicable.
NASA Johnson Space Center

POSTED

2 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Grant
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain BarrierThe Eunice Kennedy Shriver National Institute of Child Health and Human Development is advancing its mission to improve maternal, fetal, and child health by launching a second phase of the Transporter Elucidation Network, focused on understanding how biological transporters and local metabolic processes regulate exposure to nutrients, medications, microbiome-derived compounds, and environmental chemicals across critical perinatal barriers. This initiative will develop comprehensive multi-barrier frameworks that connect the maternal gut, placenta, lactating mammary epithelium, infant gut, and infant blood-brain barrier, building on prior organ-specific research to create standardized models, resources, and prototype multi-compartment systems that reflect the dynamic interplay of transporters, their polarity, kinetics, and biotransformation capacities during pregnancy, lactation, and infant development. The goal is to deepen mechanistic insights into how these systems influence nutrient delivery, drug distribution, and neurodevelopmental outcomes in early life. This phase will establish community-wide resources to support integrated studies of perinatal exposure, risk assessment, and targeted interventions across linked maternal-fetal-infant systems, while strengthening collaboration among researchers and accelerating the sharing of tools and data. Emphasis is placed on human-based and developmentally relevant models to ensure biological accuracy and translational impact. The effort also aims to cultivate a next-generation workforce skilled in transporter science, fostering innovation in pediatric pharmacology and neonatal health. Authorized under 42 U.S.C. § 241, the initiative is being led by the Obstetric and Pediatric Pharmacology and Therapeutics Branch of NICHD, with inquiries directed to their designated point of contact, and the opportunity was publicly forecasted on July 16, 2026.
National Institutes Of Health

POSTED

2 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Hypobaric Chamber Pilot StudiesNASA Johnson Space Center is soliciting offers for pilot chamber testing facilities capable of conducting hypobaric Decompression Sickness (DCS) studies under solicitation number 80JSC026Q0006, issued as a combined synopsis and solicitation per FAR Part 12 for commercial products and services. The requirement calls for three test days of data collection and recording following established research protocols, with detailed specifications outlined in Attachment A – Statement of Work and additional submission criteria in Attachment D dated July 15, 2026. The solicitation is open to all responsible sources without set-aside restrictions, and offerors must declare their size status under NAICS code 541714 with a 1,000-employee size standard. Evaluation of proposals will prioritize technical acceptability, followed by past performance, and then price, as specified in FAR 52.212-2. Offers must comply with applicable clauses including FAR 52.212-1, 52.212-2, and 52.212-4, as well as NASA-specific clauses such as the Ombudsman provision. All submissions must be delivered electronically to Tracy.L.Quintanilla@nasa.gov and Katelyn.R.Jaime@nasa.gov no later than August 24, 2026, at 1:00 p.m. Central Time. Questions must be submitted via email by July 29, 2026, same time, with no telephone inquiries accepted. Prospective offerors are encouraged to notify the point of contact of their intent to respond, and it is the offeror’s responsibility to download all documents from SAM.gov and ensure timely submission, as late or incomplete offers will be rejected in accordance with FAR provisions.
NASA Johnson Space Center

POSTED

3 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Purchase of Methylation Custom Probes for sequencingThe National Institutes of Health, under the Department of Health and Human Services, is seeking proposals for the purchase of customized methylation probes designed for sequencing applications. The solicitation, identified by number 75N98026Q00783, was posted on July 14, 2026, with a response deadline of July 21, 2026, at 8:00 PM Eastern Time. This is a combined solicitation with no set-aside designation, meaning it is open to all eligible businesses regardless of size or ownership characteristics. The North American Industry Classification System code for this procurement is 541714, indicating it pertains to research and development in the physical, engineering, and life sciences. The contract will be administered from the agency’s office in Bethesda, Maryland, with performance expected to occur in Durham, North Carolina, at a ZIP code of 27709. All inquiries and submissions should be directed to Francisca K. Wagstaff, the primary point of contact, via email at wagstaff@nih.gov. The full solicitation details and submission portal are accessible through the SAM.gov website using the provided URL.
National Institutes Of Health Olao

POSTED

4 days ago

DEADLINE

in 3 days
View Details
NAICS: 541714
New
Grant
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)The National Cancer Institute is soliciting R33 grant applications to support the advanced development and rigorous validation of emerging technologies aimed at advancing cancer research and clinical care. This opportunity is intended for projects that have already addressed major feasibility barriers, as demonstrated by strong preliminary data, but require further refinement, optimization, and technical validation to achieve broad adoption within the scientific community. The focus is on technologies with new or substantially improved capabilities for measuring, analyzing, modeling, or interrogating cancer-related biological systems, including advanced molecular and cellular platforms, multi-omic and spatial profiling methods, next-generation imaging and sensing tools, immuno-engineering approaches, and innovations in biospecimen handling and quality assessment. Proposals must center on cancer-specific applications, and applications that merely apply established technologies to novel biological questions without technological innovation are not eligible. This funding opportunity is part of the NCI’s Innovative Molecular Analysis Technologies Program and explicitly prohibits clinical trials. The goal is to accelerate progress in areas such as cancer biology, early detection, diagnosis, treatment, control, and epidemiology by enabling technologies that offer transformative potential for the research community. Projects must demonstrate clear potential for widespread utility in cancer research while maintaining a tight focus on technical advancement rather than application-specific hypotheses. All applications must be submitted through the designated grants portal, and inquiries should be directed to the IMAT Program Contact provided. The opportunity was posted in July 2026 and is open to applicants seeking to bridge the gap between initial innovation and scalable adoption in cancer science.
National Institutes Of Health

POSTED

4 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Advancing Outbreak Detection, Notification, and Response Capacity by Implementing 7-1-7 in Partner CountriesThis funding opportunity supports the strengthening of public health systems in partner countries outside the United States and its territories to achieve the 7-1-7 target—detecting biological threats within seven days, notifying relevant authorities within one day, and initiating a coordinated response within seven days. The initiative advances U.S. global health interests by building sustainable, locally led capacities for outbreak detection, notification, and response, with an emphasis on burden sharing, accountability, and efficiency. Activities include enhancing surveillance infrastructure, expanding laboratory networks, improving cross-sector and cross-border data flow, and strengthening emergency response operations to mitigate health and economic impacts. Implementation is targeted in countries where CDC has an established presence, including Bangladesh, Ghana, India, Kenya, and others, with the ultimate goal of fostering long-term self-reliance and stability in recipient nations. The solicitation, issued as a Notice of Funding Opportunity under CDC-RFA-JG-26-0214, is open for applications through Grants.gov with a deadline of August 14, 2026, and anticipated award start date of September 30, 2026, for a five-year performance period. Applications must be submitted as a cohesive package under a 90-page limit for all appendices and supporting materials, with a cap of 60 pages for the project narrative and one page for the summary. Applicants must demonstrate organizational capacity, past experience, and a robust evaluation and performance measurement plan, with evaluation weighted toward background and approach (35 points) and organizational capacity (35 points), followed by evaluation and performance measurement (30 points). Awards are made through a merit-based trade-off process, not LPTA, and may be influenced by geographic diversity and public health priorities. Recipients must adhere to 2 CFR 200 regulations, submit required financial and performance reports, and comply with CDC’s priorities including transparency and evidence-based practice. Special requirements include providing a detailed organizational chart, resumes for key personnel, an indirect cost agreement if claiming overhead, and a letter to qualify for local partner funding preference, which may yield a 10-point bonus. All applicants must hold an active Unique Entity ID via SAM.gov, and project implementation must occur exclusively outside U.S. borders.
Centers For Disease Control-Ghc

POSTED

4 days ago

DEADLINE

in 27 days
View Details
NAICS: 541714
New
Federal
Multiscale Reasoning For Human Physiology RFIThe Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking input on cutting-edge technologies that enable multiscale reasoning across human physiology through this Request for Information, identified as DARPA-SN-26-100. The focus is on emerging tools including artificial intelligence systems, foundation models, computational frameworks, and datasets capable of integrating biological, physiological, and clinical data across multiple scales—from molecular and cellular levels to organ systems and whole-body responses. The goal is to advance the ability to model, predict, and interpret complex human physiological behavior using AI and data-driven approaches, with interest in non-traditional performers and innovative solutions from industry, academia, government labs, and healthcare organizations. Responses are due by August 10, 2026, and the solicitation falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. All submissions should be directed to Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, via bioreasoning@darpa.mil. The office is located in Arlington, Virginia, and while no specific place of performance is defined, selected technologies may be developed and evaluated through future DARPA programs. This RFI does not constitute a solicitation for proposals or obligations but aims to inform upcoming funding opportunities in the field of physiological modeling and AI-driven biological insight.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 23 days
View Details
NAICS: 541714
Federal
Technical Support and Product Training for EMIT Assay SystemsThe contract provides for on-site or remote technical assistance, system calibration, and training services specifically tailored for laboratory personnel working with EMIT II Plus Assay systems and their associated reagents. This support is critical to ensure accurate operation, proper maintenance, and effective use of the analytical equipment, enabling consistent and reliable test results in laboratory settings. The scope encompasses hands-on training, troubleshooting guidance, and periodic calibration to meet performance standards, with services deliverable either at the client’s facility or through virtual means as needed. This subcontract is associated with the Department of Defense under the agency identifier FA3016 502 Cons Cl and is classified under NAICS code 541714, indicating scientific and technical consulting services. The place of performance is designated as DWG with a zip code of 78236, suggesting the primary operational location is in or near San Antonio, Texas. The solicitation was posted on July 10, 2026, with a response deadline of July 20, 2026, at 3:00 PM, requiring interested parties to submit proposals within this narrow window. The contract does not specify any set-aside status, and no point of contact information has been provided in the posting.
FA3016 502 Cons Cl

POSTED

8 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
Federal
Tape-Out Ready Physical Design & EDA SupportThe contract requires the production of GDSII and OASIS layout files along with IBIS models, S-parameters, and eye diagrams to validate signal and power integrity for tape-out readiness on Intel’s 18A process node. All deliverables must meet stringent industry standards to ensure the physical design is fully optimized and compliant for manufacturing, with a focus on minimizing signal degradation, electromagnetic interference, and power delivery issues. The work must be executed with precision to support seamless transition from design to fabrication, ensuring the final product meets electrical and performance targets. This is a subcontract under NAICS code 541714, issued by the Department of Defense via FA8002 Saf Aq, with a response deadline of July 23, 2026, and a posting date of July 8, 2026. The place of performance and specific point of contact are not detailed in the provided data, but the scope clearly demands advanced EDA expertise and close alignment with Intel’s 18A process requirements. All deliverables must be submitted in recognized industry formats and accompanied by verification data to confirm compliance with reliability and performance benchmarks necessary for defense applications.
FA8002 Saf Aq

POSTED

10 days ago

DEADLINE

in 5 days
View Details
NAICS: 541714
Federal
Secure Enclave Integration & Validation ServicesThe contract seeks qualified vendors to validate chiplet designs within the Government’s Secure Enclave, specifically focusing on adherence to open industry standards such as UCIe. This work involves the secure handling, rigorous testing, and comprehensive verification of chiplet interoperability to ensure compatibility, reliability, and protection of sensitive hardware architectures. All activities must comply with stringent security protocols mandated by the Department of Defense to safeguard intellectual property and maintain the integrity of the Secure Enclave environment throughout the validation lifecycle. Performance is expected to align with the NAICS code 541714, indicating specialized research and development in engineering services. The subcontract opportunity is open for response until July 23, 2026, and is administered by the Saf Aq office under the Department of Defense. While specific location details are not provided, all work must be conducted in a manner that meets federal security requirements, and successful bidders must demonstrate proven expertise in secure chiplet validation, open standard implementation, and secure testing methodologies within defense-critical systems.
FA8002 Saf Aq

POSTED

10 days ago

DEADLINE

in 5 days
View Details
NAICS: 541714
Federal
TECHNOLOGY LICENSING OPPORTUNITY: Platform to Accelerate Discovery of Tailored Industrial Enzymes (PAD-TIE)The PAD-TIE platform, developed by NREL and Los Alamos National Laboratory, is a high-throughput screening system designed to rapidly identify and optimize enzymes capable of breaking down polyethylene terephthalate (PET) plastic under industrially relevant conditions. Unlike traditional methods that test enzymes one at a time, PAD-TIE evaluates tens of thousands of enzyme variants simultaneously, measuring their activity, stability, and production efficiency in a single process, eliminating costly purification steps and reducing time-to-identification. The system operates at the optimal temperature for PET degradation and is validated in lab-scale bioreactors that mimic real-world recycling environments, enabling the conversion of plastic waste into reusable monomers without harsh chemicals or excessive energy use. With a Technology Readiness Level of 6, the platform is a fully functional prototype with all components tested, and three U.S. patents are pending, making it a mature and protected innovation ready for commercial adoption. PAD-TIE is positioned to serve a broad range of industries including plastic recycling, waste management, polymer manufacturing, and sustainable materials development. Its adaptability allows customization for different PET compositions, additives, and processing conditions, ensuring compatibility with existing infrastructure. The platform’s efficiency and scalability offer a cost-effective solution for scaling enzymatic plastic degradation at an industrial level. Los Alamos National Laboratory is seeking industry partners through exclusive or non-exclusive licensing agreements to further develop and deploy the technology, with applications spanning bioremediation, bioplastics, and closed-loop recycling systems. Interested parties must respond by October 1, 2026, and inquiries should be directed to the provided licensing contacts. The technology is available for commercialization under a non-set-aside procurement with a NAICS code of 541714, and performance will occur in Los Alamos, New Mexico.
Triad - DOE Contractor

POSTED

10 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
Federal
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)The Biomedical Advanced Research and Development Authority (BARDA) is seeking proposals under solicitation 75A50126R00002 to develop, obtain regulatory approval for, and procure approximately two million 2-PAM (600mg) autoinjectors as a drug/device combination product for the treatment of organophosphate poisoning, including nerve agents, in both adult and pediatric populations. This effort supports the Strategic National Stockpile (SNS) and CHEMPACK Program. The contract is structured as a hybrid cost-plus-fixed-fee and firm-fixed-price instrument with an anticipated base performance period of up to 36 months and potential extension through options to a total duration of eight years. Key deliverables include late-stage clinical development, regulatory submission and approval, and large-scale manufacturing of autoinjectors, with production split across multiple CLINs totaling 2 million units. The solicitation is issued as a Statement of Objectives, requiring offerors to submit a comprehensive Statement of Work and Risk Mitigation Plan addressing program management, product development, supply chain logistics, and optional post-marketing commitments. Manufacturing and packaging must adhere to Good Manufacturing Practice regulations under 21 CFR Part 820, and all products must maintain strict temperature controls during transit, with ambient exposure logging required from the offeror’s validated facility until acceptance by the government at the ASPR/SNS location in Washington, D.C. All proposals must comply with mandatory eligibility criteria, including adherence to FAR and HHSAR clauses covering cost allowability, inspection, intellectual property, anti-kickback, and contingency fee restrictions. Offerors are required to complete SAM.gov representations and certifications, submit a detailed organizational chart identifying key personnel including a Program Director, Chief Scientific/Medical Officer, Manufacturing Lead, Regulatory Affairs Lead, and Project Manager, and demonstrate compliance with human subject protections under 45 CFR 46. Security requirements mandate layered physical controls, identification verification for personnel and visitors, and robust information and cyber security protocols encompassing access controls, intrusion detection, and encryption. Proposals must be submitted by July 30, 2026, and remain firm for 120 days. Evaluation will prioritize technical merit, past performance, and overall value over cost, with non-cost factors carrying significantly greater weight. Contract administration requires electronic invoice submissions via the Treasury IPP system to designated federal offices and strict adherence to documentation handling, packaging, and delivery protocols. The procurement is open to all qualified entities without set-aside restrictions
Barda - Aspr / Daappo / Barda Dcma

POSTED

10 days ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services

Same awarding agency

NAICS: 325120
New
Federal
Blanket Purchase Agreement to supply liquid and compressed gas services of contractor-owned gas cylindersThis Blanket Purchase Agreement is issued to secure liquid and compressed gas services through contractor-owned cylinders to ensure a continuous and adequate supply for the Health Effects Laboratory Division at the NIOSH Morgantown Facility in West Virginia. The contractor is also required to provide dry ice, with historical capacity standards indicating a need to maintain up to 300 pounds of dry ice pellets in the designated blue bin on site. The solicitation is a Total Small Business Set-Aside under FAR 19.5, restricting eligibility to small businesses, and is classified under NAICS code 325120 for chemical manufacturing. The contracting activity is managed by the CDC Office of Acquisition Services under the Department of Health and Human Services, with the primary point of contact being Jennifer Gartzke at xuy7@cdc.gov. Amendment 1 extends the deadline for submitting questions to July 16, 2026, and moves the response submission deadline to July 24, 2026, with the original posting date being July 17, 2026. The place of performance is Morgantown, West Virginia, 26505, while the contracting office is located in Atlanta, Georgia. No contract value, pricing details, evaluation criteria, delivery schedules, inspection standards, packaging requirements, or special clauses were provided in the available documentation.
Industrial Gas Manufacturing

POSTED

about 21 hours ago

DEADLINE

in 4 days
View Details
NAICS: 813920
New
Federal
Notice of Intent to Sole Source - Outreach, Training, and Virtual Certification Opportunities to Increase the Number of B-Readers in the United States (Virtual Course)
Professional Organizations

POSTED

about 21 hours ago

DEADLINE

in 14 days
View Details
NAICS: 325414
New
Federal
(Presolicitation Notice) Intent to Sole Source - BioRad Antibodies
Biological Product (except Diagnostic) Manufacturing

POSTED

about 21 hours ago

DEADLINE

in 14 days
View Details
NAICS: 811210
New
Federal
Peak Sci Nitrogen Generator PMAThe Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Peak International Group Ltd. for an equipment maintenance agreement covering two Peak Scientific Genius XE35 nitrogen gas generators, identified by serial numbers 722100430 and 724060569, which are critical to supporting mass spectrometers and DNA sequencers within the Biotechnology Core Facility Branch. The service contract mandates a Complete Plan 48/72 Service Plan (SL3a-Tier-NA), including on-site service with a maximum 48-hour response time, unlimited parts replacement, engineer labor and travel, priority technical support, and one scheduled preventative maintenance visit per year. Peak Scientific is the sole authorized source for original equipment manufacturer parts and services, as the company does not train, authorize, or support any third-party vendors for maintenance or repair, making competition impossible under federal procurement rules. The procurement is justified under FAR 13.106-1(b)(1)(i) due to the exclusive nature of OEM parts and service authorization. The National Institute of Standards and Technology NAICS code 811210 applies to this requirement. Interested parties must submit a capability statement not exceeding two pages in length, using 10-point font or larger, in Microsoft Word or PDF format, by 12:00 PM Eastern Standard Time on July 22, 2026, exclusively via email to zsm9@cdc.gov. No telephone inquiries or offers will be accepted. The government will evaluate submissions solely to determine whether competitive procurement is feasible or if the sole source award should proceed. The anticipated award date is on or before August 1, 2026, and this notice is not a solicitation for competitive bids.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 513120
New
Federal
Publish Infant Feeding Practices Study Journal Supplement to American Academy of Pediatrics
Periodical Publishers

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 811210
New
Federal
AB SCIEX MDQ PMA PACE MDQ PlusThe Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to AB SCIEX, LLC for an annual preventative maintenance agreement covering the AB SCIEX PACE MDQ Plus Capillary System, serial number B525230047. This procurement is justified under FAR 13.106-1(b)(1)(i) due to the proprietary nature of the system, which includes exclusively manufactured parts and software only available through AB SCIEX, making it the sole provider capable of servicing the equipment. The contractor must deliver comprehensive maintenance services including one annual scheduled preventative maintenance visit with full system diagnostics and critical part replacement, unlimited breakdown calls, and prioritized response within 24 to 48 hours for any failures, covering all labor, travel, and parts required. The solicitation is not open to competitive bidding; however, interested parties must submit a capability statement no longer than two pages, using no smaller than 10-point font, in Microsoft Word or Adobe PDF format to Javier Aponte at zsm9@cdc.gov by 12:00 PM Eastern Standard Time on July 22, 2026. The statement must provide detailed management and technical information along with cost data and verifiable proof of authorized distributor status. Telephone inquiries or submissions will not be accepted. The anticipated award date is on or before August 1, 2026, and the procurement falls under NAICS code 811210 for Electronic and Precision Equipment Repair and Maintenance. All submissions will be evaluated solely to determine whether to proceed with a sole source award or reconsider competition, with the government retaining full discretion over the decision.
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 811210
New
Federal
TX Bio ABI-3900 PMA
Electronic and Precision Equipment Repair and Maintenance

POSTED

2 days ago

DEADLINE

in 4 days
View Details
New
Federal
Notice of Intent to Award to Sole Source -COOLED STACK SERVICE CONTRACT

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 325413
New
Federal
Notice of Intent to Sole Source Reagents, calibrators and controls to be used in conjunction with the VITROS 3600 Immunodiagnostic system, manufactured by QuidelOrtho Sales Company, LLC
In-Vitro Diagnostic Substance Manufacturing

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 492110
New
Federal
RFI: Specialized Domestic and International Cold-Chain Logistics Services for the International Reagent Resource (IRR)The Centers for Disease Control and Prevention, through the National Center for Immunization and Respiratory Diseases, is seeking information from commercial logistics providers capable of supporting the domestic and international cold-chain distribution of diagnostic reagents, influenza viruses, molecular detection materials, and other temperature-sensitive biological products used for respiratory pathogen detection. These materials, handled and prepared at the American Type Culture Collection facility in Manassas, Virginia, require strict temperature controls—including refrigerated, frozen, and ultra-low temperature environments—as well as compliance with IATA, ICAO, DOT, and international regulatory standards. The logistics provider must ensure end-to-end chain-of-custody, real-time shipment tracking, validated packaging, and continuous cold-chain monitoring throughout transit, with the ability to respond to excursions and maintain product integrity under demanding conditions. The program also demands robust customs clearance support, import/export documentation assistance, dry ice replenishment during long-haul transit, and customer service available across multiple time zones to facilitate global delivery to public health labs, ministries of health, and research institutions. The request for information seeks detailed capabilities of vendors, including experience transporting biological and medical products, cold-chain infrastructure, temperature ranges supported, monitoring technologies, customs brokerage expertise, and international shipping reach, particularly in support of government and public health entities. Respondents must describe surge capacity for responding to seasonal influenza events or emerging disease outbreaks, quality management systems such as ISO or GDP compliance, IATA Dangerous Goods certifications, and performance metrics for on-time delivery and shipment integrity. The CDC is evaluating market readiness to inform future procurement requirements and is not soliciting bids or pricing at this stage. Responses must be submitted electronically in PDF format within ten pages, and must include both primary and secondary points of contact. The opportunity is open to all qualified providers, with no obligation to issue a contract, and submission is voluntary and at the respondent’s expense.
Couriers and Express Delivery Services

POSTED

3 days ago

DEADLINE

in 28 days
View Details
NAICS: 334516
New
Federal
Maintenance/Service contract for Biaera AeroMPThe U.S. Centers for Disease Control and Prevention, through the Office of Acquisition Services within the Department of Health and Human Services, intends to award a sole source maintenance contract to Biaera Technologies LLC for the servicing of two AeroMP units. The action is being conducted under simplified acquisition procedures outlined in FAR 13, specifically leveraging FAR 13.106-1(b) and Subpart 12.6, which permit solicitation from a single source for commercial items. The procurement is classified under NAICS code 334516 and Product Service Code H366, and no formal solicitation or competition is currently active. This notice serves exclusively to gauge market interest and gather technical and pricing data from potential vendors to support the government’s determination on whether to proceed with a non-competitive award. All submissions of interest must be emailed to qty0@cdc.gov no later than 10:00 AM ET on July 21, 2026, and must include comprehensive details demonstrating capability to meet the requirement. The government retains full discretion to proceed without competition based on the information received, and no formal proposal or quotation will be solicited in response to this notice. The point of contact for inquiries is Brian Swann, and the maintenance work is to be performed in Maryland.
Analytical Laboratory Instrument Manufacturing

POSTED

3 days ago

DEADLINE

in 2 days
View Details
NAICS: 541715
New
Federal
Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever)The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Valley Fever Solutions, INC, through the Valley Fever Center for Excellence at the University of Arizona, to develop, evaluate, and validate diagnostic methods for coccidioidomycosis, commonly known as Valley Fever. The project will utilize the center’s established biospecimen repository and clinical infrastructure to advance diagnostic assays, with additional specimen collection and enhanced storage capacity being implemented to meet expanded research demands. All work will be conducted exclusively at the Valley Fever Center for Excellence in Tucson, Arizona, with no performance occurring at CDC facilities. The contract is classified under Product or Service Code AN12 for Health R&D Services and NAICS Code 541715 for Research and Development in the Life Sciences, with a performance period spanning from September 30, 2026, to September 29, 2027. This procurement is being conducted under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1), allowing for non-competitive award due to the unique expertise and existing infrastructure of the Valley Fever Center for Excellence. Although this is a notice of intent for a sole source acquisition and not a competitive solicitation, interested parties may submit responses by 11:00 AM Eastern Time on July 29, 2026, to dwb7@cdc.gov. The government retains full discretion to determine whether competition will be pursued based on responses received. The contract is designated as a total small business set-aside, and all correspondence and submissions must be directed to the primary point of contact, Marquetta Taylor, at the CDC Office of Acquisition Services in Atlanta, Georgia.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

in 11 days
View Details